New England Research & Management, Inc. Charles River Laboratories International, Inc. Transaction History

New England Research & Management, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Jun 15, 2020	SELL	$98.9 - $178.34 $445,050 - $802,530	-4,500 Closed	0 $0
Q4 2019 Jan 14, 2020	SELL	$126.05 - $152.76 $280,461 - $339,891	-2,225 Reduced 33.09%	4,500 $687,000
Q3 2019 Nov 04, 2019	SELL	$125.07 - $143.67 $31,267 - $35,917	-250 Reduced 3.58%	6,725 $890,000
Q2 2019 Jul 09, 2019	BUY	$123.4 - $148.55 $860,715 - $1.04 Million	6,975 New	6,975 $990,000
Q1 2019 Apr 03, 2019	SELL	$104.82 - $146.73 $345,906 - $484,208	-3,300 Closed	0 $0

Q4 2018 Jan 11, 2019	SELL	$105.09 - $137.23 $788,175 - $1.03 Million	-7,500 Reduced 69.44%	3,300 $373,000
Q3 2018 Oct 03, 2018	BUY	$112.11 - $134.54 $1.21 Million - $1.45 Million	10,800 New	10,800 $1.45 Million

728

51.3M

183K

346K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.2B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of New England Research & Management, Inc., based on Form 13F filings with the SEC.

Stay updated on New England Research & Management, Inc. with notifications on news.